Responses of growth hormone to desipramine in endogenous and non-endogenous depression.
case_control · Level III
Where this comes from
- Record sourced from PubMed, PMID 2095944.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Desipramine, a monoamine reuptake inhibitor, was used to stimulate release of growth hormone (GH) in 29 DSM-III major depressives and in 10 healthy controls. Eighteen of the depressives showed a blunted response. The GH-stimulation test was unable to distinguish endogenous from non-endogenous patients. The 13 dexamethasone non-suppressors were more likely to have a blunted GH response than the 14 suppressors. The results indicate that at least a subset of non-endogenous depressives have significant neuroendocrine abnormality.
Medical subject headings
- Bipolar Disorder
- Depressive Disorder
- Desipramine
- Growth Hormone
- Psychotic Disorders